Tactile Systems Technology Inc
NASDAQ:TCMD

Watchlist Manager
Tactile Systems Technology Inc Logo
Tactile Systems Technology Inc
NASDAQ:TCMD
Watchlist
Price: 13.27 USD -0.97% Market Closed
Market Cap: 313m USD

Tactile Systems Technology Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tactile Systems Technology Inc
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Tactile Systems Technology Inc
NASDAQ:TCMD
Pre-Tax Income
$23.5m
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
20%
Becton Dickinson and Co
NYSE:BDX
Pre-Tax Income
$2B
CAGR 3-Years
20%
CAGR 5-Years
18%
CAGR 10-Years
3%
Boston Scientific Corp
NYSE:BSX
Pre-Tax Income
$2.3B
CAGR 3-Years
28%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Pre-Tax Income
$3.5B
CAGR 3-Years
15%
CAGR 5-Years
6%
CAGR 10-Years
12%
Abbott Laboratories
NYSE:ABT
Pre-Tax Income
$7B
CAGR 3-Years
-5%
CAGR 5-Years
11%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Pre-Tax Income
$2.7B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
17%

Tactile Systems Technology Inc
Glance View

Market Cap
316.9m USD
Industry
Health Care

Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

TCMD Intrinsic Value
16.19 USD
Undervaluation 18%
Intrinsic Value
Price

See Also

What is Tactile Systems Technology Inc's Pre-Tax Income?
Pre-Tax Income
23.5m USD

Based on the financial report for Dec 31, 2024, Tactile Systems Technology Inc's Pre-Tax Income amounts to 23.5m USD.

What is Tactile Systems Technology Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
20%

Over the last year, the Pre-Tax Income growth was 49%.

Back to Top